The realisation that NF- kappaB activity is regulated by kinases and ubiquitin modifying enzymes presents multiple opportunities for therapeutic intervention. In addition to highlights from basic research, results from clinical trials using IKK and other NF- kappaB inhibitors are expected to be presented at this meeting.
Keystone Symposia: NF-kappaB in Inflammation and Disease
5 - 10 January 2010, Santa Fe, New Mexico, United States
Introduction
Venue
Eldorado Hotel & Spa
Eldorado Hotel & Spa, Santa Fe, New Mexico, United States
Organised by
Michelle A. Kelliher, Manolis Pasparakis and J眉rg Tschopp
Contact information
Related events
Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
RSC Energy Sector Next Generation Materials for Solar Photovoltaics 2025
16 January 2025, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
